Skip to Content

Rayzon

Active Substance: parecoxib
Common Name: parecoxib
ATC Code: M01AH04
Marketing Authorisation Holder: Pharmacia Europe EEIG
Active Substance: parecoxib
Status: Withdrawn
Authorisation Date: 2002-03-22
Therapeutic Area: Pain, Postoperative
Pharmacotherapeutic Group: Antiinflammatory and antirheumatic products

Therapeutic Indication

For the short-term treatment of postoperative pain.
The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the
individual patient's overall risks (see sections 4.3, 4.4).

The marketing authorisation for Rayzon has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide